Diffusion-weighted imaging and FDG PET/CT: predicting the prognoses with apparent diffusion coefficient values and maximum standardized uptake values in patients with invasive ductal carcinoma

BackgroundFDG PET/CT and DWI are both functional modalities that indirectly represent the biological characteristics of cancer, but there are few studies exploring the association between the two modalities and prognostic factors. Our study attempted to evaluate the mutual association by comparing the prognostic factors, SUVmax value of PET/CT, and ADC values associated with diffusion imaging in invasive ductal carcinoma (IDC) patients.MethodsPatients with pathologically confirmed IDC were recruited. There were 118 patients who underwent MRI, including DWI, FDG PET/CT, and immunohistochemical staining of the surgical specimen. Histologic analysis was done on tumor size, lymph node metastasis, expression of estrogen receptors (ER), progesterone receptors (PR), human epidermal growth factor receptor 2 (HER2), Ki-67, and epidermal growth factor receptors (EGFR). The relationship among ADC values, SUVmax and prognostic factors were evaluated.ResultsThere was significant association between the ADC value and ER-positive and HER2-negative expression. Significant associations were noted between SUVmax and tumor size, lymph node metastasis, histologic grade, ER and PR expression, EGFR and Ki-67. However, there was no significant correlation between the ADC value and SUVmax.ConclusionsEven though there was no correlation between ADC and SUVmax, both indexes are useful for predicting the prognosis of IDC.

[1]  Y. Kajiya,et al.  FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  S. Mousa,et al.  Estrogen Receptor-α in the Inhibition of Cancer Growth and Angiogenesis , 2000 .

[3]  G. Hortobagyi,et al.  Prognostic molecular markers in early breast cancer , 2004, Breast Cancer Research.

[4]  Steven Sourbron,et al.  Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings--preliminary results. , 2008, Radiology.

[5]  H. Yagata,et al.  Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2‐deoxy‐2‐fluoro[18F]‐D‐glucose , 1998, Cancer.

[6]  Sung Hun Kim,et al.  Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma , 2011, Journal of magnetic resonance imaging : JMRI.

[7]  Paul J. van Diest,et al.  Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography , 2002 .

[8]  Masao Tanaka,et al.  Standardized Uptake Values for Breast Carcinomas Assessed by Fluorodeoxyglucose-Positron Emission Tomography Correlate with Prognostic Factors , 2007, The American surgeon.

[9]  Hiroshi Honda,et al.  Apparent diffusion coefficients of breast tumors: clinical application. , 2008, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[10]  David J Collins,et al.  Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy , 2008, Nature Clinical Practice Oncology.

[11]  H. Tsuda,et al.  Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer. , 2008, Japanese journal of clinical oncology.

[12]  Yutaka Imai,et al.  Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer , 2008, Radiation Medicine.

[13]  Takashi Kato,et al.  Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity , 1996, European Journal of Nuclear Medicine.

[14]  T. Yen,et al.  Correlation of apparent diffusion coefficients measured by 3T diffusion-weighted MRI and SUV from FDG PET/CT in primary cervical cancer , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  B. Kang,et al.  Diffusion‐weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors , 2009, Journal of magnetic resonance imaging : JMRI.

[16]  Bong Joo Kang,et al.  The Role of Diffusion-Weighted Imaging and the Apparent Diffusion Coefficient (ADC) Values for Breast Tumors , 2007, Korean journal of radiology.

[17]  Masahiko Watanabe,et al.  Diffusion-Weighted Imaging of Malignant Breast Tumors: The Usefulness of Apparent Diffusion Coefficient (ADC) Value and ADC Map for the Detection of Malignant Breast Tumors and Evaluation of Cancer Extension , 2005, Journal of computer assisted tomography.

[18]  M. Tonato,et al.  Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients , 2003, Breast Cancer Research and Treatment.

[19]  Yoshito Tsushima,et al.  Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5‐T , 2009, Journal of magnetic resonance imaging : JMRI.

[20]  P. V. van Diest,et al.  Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A. Razek,et al.  Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors , 2010, NMR in biomedicine.

[22]  S G Hilsenbeck,et al.  Significance of axillary lymph node metastasis in primary breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Prescott,et al.  Tumour cellularity, oestrogen receptors and prognosis in breast cancer. , 1983, Clinical oncology.

[24]  A Horsman,et al.  Prediction of axillary lymph node status in invasive breast cancer with dynamic contrast-enhanced MR imaging. , 1997, Radiology.

[25]  Shigeru Nawano,et al.  Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[26]  A. Cilotti,et al.  Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion , 2007, European Radiology.

[27]  Ning-Yu An,et al.  Differentiation of clinically benign and malignant breast lesions using diffusion‐weighted imaging , 2002, Journal of magnetic resonance imaging : JMRI.

[28]  Woo Kyung Moon,et al.  Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer , 2011, European Radiology.